| NCT ID | NCT06745830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | Lung Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,998 participants |
| Start Date | 2024-04-10 |
| Primary Completion | 2024-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,998 participants in total. It began in 2024-04-10 with a primary completion date of 2024-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The percentage of high-grade patterns in metastatic LNs (mLNs) that can predict poor outcomes has yet to be determined. Additionally, the potential implications of other histologic patterns in metastatic lymph nodes on patient outcomes warrant further investigation. We conducted a retrospective cohort study to investigate the prognostic value of pathologic pattern in metastatic lymph nodes.
Eligibility Criteria
Inclusion Criteria: From January 2011 to September 2021, we consecutively collected patients with invasive LUAD who underwent surgical resection at the Department of Thoracic Surgery, Fudan University Shanghai Cancer Center. Exclusion Criteria: 1. adenocarcinoma in situ, minimally invasive adenocarcinoma, invasive mucinous adenocarcinoma, and other variants of adenocarcinoma; 2. incomplete common driver mutation data; 3. unavailable pathologic slides.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06745830 clinical trial?
This trial is open to participants of all sexes, studying Lung Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06745830 currently recruiting?
Yes, NCT06745830 is actively recruiting participants. Contact the research team at 20301050177@fudan.edu.cn for enrollment information.
Where is the NCT06745830 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06745830 clinical trial?
NCT06745830 is sponsored by Fudan University. The trial plans to enroll 2,998 participants.